These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 18834326)

  • 21. Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinations.
    Lizis-Kolus K; Kowalska A; Kozak-Klonowska B; Siołek M; Słuszniak J; Lubiński J; Cybulski C
    Endokrynol Pol; 2010; 61(5):502-6. PubMed ID: 21049466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis.
    Liu C; Wang QS; Wang YJ
    Asian Pac J Cancer Prev; 2012; 13(5):2051-5. PubMed ID: 22901170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CHEK2 gene and inherited breast cancer susceptibility.
    Nevanlinna H; Bartek J
    Oncogene; 2006 Sep; 25(43):5912-9. PubMed ID: 16998506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.
    Serrano-Fernández P; Debniak T; Górski B; Bogdanova N; Dörk T; Cybulski C; Huzarski T; Byrski T; Gronwald J; Wokołorczyk D; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2009 Sep; 117(1):161-5. PubMed ID: 19030985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
    Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
    Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy.
    Meyer A; Dörk T; Sohn C; Karstens JH; Bremer M
    Radiother Oncol; 2007 Mar; 82(3):349-53. PubMed ID: 17250914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.
    de Bock GH; Schutte M; Krol-Warmerdam EM; Seynaeve C; Blom J; Brekelmans CT; Meijers-Heijboer H; van Asperen CJ; Cornelisse CJ; Devilee P; Tollenaar RA; Klijn JG
    J Med Genet; 2004 Oct; 41(10):731-5. PubMed ID: 15466005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations.
    Hall J; Marcel V; Bolin C; Fernet M; Tartier L; Vaslin L; Hainaut P
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):527-33. PubMed ID: 19442246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
    van Puijenbroek M; van Asperen CJ; van Mil A; Devilee P; van Wezel T; Morreau H
    J Pathol; 2005 Jun; 206(2):198-204. PubMed ID: 15818573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme.
    Simon M; Ludwig M; Fimmers R; Mahlberg R; Müller-Erkwoh A; Köster G; Schramm J
    Neurosurgery; 2006 Nov; 59(5):1078-85; discussion 1085. PubMed ID: 17016233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
    Laitman Y; Kaufman B; Lahad EL; Papa MZ; Friedman E
    Isr Med Assoc J; 2007 Nov; 9(11):791-6. PubMed ID: 18085035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common variants of DNA repair genes and malignant melanoma.
    Debniak T; Scott RJ; Górski B; Cybulski C; van de Wetering T; Serrano-Fernandez P; Huzarski T; Byrski T; Nagay L; Debniak B; Kowalska E; Jakubowska A; Gronwald J; Wokolorczyk D; Maleszka R; Kładny J; Lubinski J
    Eur J Cancer; 2008 Jan; 44(1):110-4. PubMed ID: 18024013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort.
    McInerney NM; Miller N; Rowan A; Colleran G; Barclay E; Curran C; Kerin MJ; Tomlinson IP; Sawyer E
    Breast Cancer Res Treat; 2010 May; 121(1):203-10. PubMed ID: 19763819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHEK2-positive breast cancers in young Polish women.
    Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Kowalska E; Oszurek O; Narod SA; Lubinski J
    Clin Cancer Res; 2006 Aug; 12(16):4832-5. PubMed ID: 16914568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.
    Cybulski C; Masojc B; Oszutowska D; Jaworowska E; Grodzki T; Waloszczyk P; Serwatowski P; Pankowski J; Huzarski T; Byrski T; Górski B; Jakubowska A; Debniak T; Wokolorczyk D; Gronwald J; Tarnowska C; Serrano-Fernández P; Lubinski J; Narod SA
    Carcinogenesis; 2008 Apr; 29(4):762-5. PubMed ID: 18281249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.
    Falchetti M; Lupi R; Rizzolo P; Ceccarelli K; Zanna I; Calò V; Tommasi S; Masala G; Paradiso A; Gulino A; Giannini G; Russo A; Palli D; Ottini L
    Breast Cancer Res Treat; 2008 Jul; 110(1):161-7. PubMed ID: 17661168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland.
    Cybulski C; Wokołorczyk D; Huzarski T; Byrski T; Gronwald J; Górski B; Debniak T; Masojć B; Jakubowska A; van de Wetering T; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2007 Mar; 102(1):119-22. PubMed ID: 16897426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Frequency of CHEK2 gene mutations in patients with breast cancer from the Republic of Bashkortostan].
    Mol Biol (Mosk); 2014; 48(1):55-61. PubMed ID: 25842825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epistatic relationship between the cancer susceptibility genes CHEK2 and p27.
    Cybulski C; Gliniewicz B; Sikorski A; Kładny J; Huzarski T; Gronwald J; Byrski T; Debniak T; Gorski B; Jakubowska A; Wokolorczyk D; Narod SA; Lubiñski J
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):572-6. PubMed ID: 17372254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
    Cybulski C; Wokołorczyk D; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Masojć B; Deebniak T; Górski B; Blecharz P; Narod SA; Lubiński J
    J Clin Oncol; 2011 Oct; 29(28):3747-52. PubMed ID: 21876083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.